Dynavax Technologies Corporation
Dynavax Technologies Corporation (DVAX) Stock Overview
Explore Dynavax Technologies Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.4B
P/E Ratio
-23.54
EPS (TTM)
$-0.50
ROE
-0.10%
DVAX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Dynavax Technologies Corporation (DVAX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 63.72, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.79.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -23.54 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.